pre-miRNA Information
pre-miRNA hsa-mir-103b-1   
Genomic Coordinates chr5: 168560904 - 168560965
Description Homo sapiens miR-103b-1 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases
pre-miRNA hsa-mir-103b-2   
Genomic Coordinates chr20: 3917502 - 3917563
Description Homo sapiens miR-103b-2 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-103b
Sequence 1| UCAUAGCCCUGUACAAUGCUGCU |23
Evidence Experimental
Experiments ChIP-seq
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN28198041 16 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs369221403 4 dbSNP
rs1283132774 7 dbSNP
rs1222085747 10 dbSNP
rs572980521 14 dbSNP
rs748411363 15 dbSNP
rs769854452 23 dbSNP
Putative Targets

Gene Information
Gene Symbol OSBPL10   
Synonyms ORP10, OSBP9
Description oxysterol binding protein like 10
Transcript NM_001174060   
Other Transcripts NM_017784   
Expression
Putative miRNA Targets on OSBPL10
3'UTR of OSBPL10
(miRNA target sites are highlighted)
>OSBPL10|NM_001174060|3'UTR
   1 TGGGGTGGAGGTGCAGAGCTTTCCAGTATAGCCCTGTTTTTGTAGGAATATTAAAGTAGTAGAGTATCAGGGTTTTGTTG
  81 GCATTCACTGAGACCTTGTATTAGCATCCAAGAAATGATGAGAGAGAGAGAAATTATATACTATGAAAAGTGCACCCCCA
 161 CACTCTGCTAGAGGAATGAATTTATTCAAGAGCCATTCGGGGCACGTGTGTGTACACACCGTATACGTTCACACACATGC
 241 ACTATGTAAACATCTGAGTATGATTACACATTTAAATACTGCACTCACCAAGGTTAAAGTGGGTAATCATAAGCTCCTTT
 321 TTATCAATGAAGTTTGAAGTTTTTCTATTTTTCACTTTGCCAAAAATGTTTTACACTCACAAAGATATTCTCACTTAGTC
 401 AACTCCTGTCAAAATGAAGGTGAACTGGCATGGCCCGATCACTGTCCATAAGGGAGAAAGTGGCTCATTCCTGGTAGAAG
 481 TATGGGTGGTTATCATTTCAAAATTATTGTGATTCTCACCTCCCTCCCCACCTCAGTGTTTTGTCTGTCCGCGCCCAAGA
 561 AAGATAAGCAAGTATTTCCTGCTGGATGGGGGTTGGCAGGAAGCTGTTAAAGATTTATGCCAGAGCCTTGCAGGATGGAG
 641 CACCTCTGGGACAACTAAGAGCCAAGGCCCACCAAGGAGTTTTCCACCCGTCTCTCATGGTCACAGCGCTAGTCATTCAT
 721 TTTTGAGAAGTTGCTTCTTTTACATCAGAAAACCAGTCAATCATATGGAGACTTCTTTTGTGATGAAAAAGGGCTTTAGA
 801 AGTTAAATACATGCATGCACATGAAAACATGCACAACCACAGCCTCAATCTTGTATTTAGTTTGGGGAAAGAGAAGAGAA
 881 TTTCCTGTGGATTATTTTTTCCTCAAGTGCACCTCTCTGGTTAACCCAAACTCTGCAAGAAAGCACTGTGACTAAAACAT
 961 ACATAACGCCTGCATAAATATTCCATGGTTTCAGTTAAATTTCAGTTTTTAGCCTTTACACATGAGGTCAAAGGAGTGAC
1041 GAAAATACAAAGCAAGGAAAAAATGAAATATCTGGTTTTTGCTGAATGCTTAATTTATTTTTTACTGTGCCACTCCAATA
1121 TTTATCAAATCCAAATAGCATGAATGCTTCTCTGTAGTAATACTAATTTTGTGCCTTTTGTCTGCTTTCTTAAGACCAGT
1201 TGTTCACACTTTGTAGATATTAGACAAATATATTTCGATTGAATACAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ucGUCGUAACAU-GUCCCGAUACu 5'
            :||:|  ||| |||||:| || 
Target 5' agTAGTAGAGTATCAGGGTTTTGt 3'
55 - 78 125.00 -20.50
2
miRNA  3' ucGUCGUAACAUGUC--CCGAUAcu 5'
            :|| |  |||::|  ||:|||  
Target 5' ggTAGAA--GTATGGGTGGTTATca 3'
473 - 495 119.00 -9.54
3
miRNA  3' ucgucgUAACAUGUCCCGAUACu 5'
                ||| ||:|   ||||| 
Target 5' agagaaATTATATA---CTATGa 3'
127 - 146 104.00 -5.90
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30155822 16 COSMIC
COSN30507290 23 COSMIC
COSN31570612 37 COSMIC
COSN30503424 43 COSMIC
COSN30105203 58 COSMIC
COSN31499287 62 COSMIC
COSN28675627 100 COSMIC
COSN30140384 121 COSMIC
COSN30115137 130 COSMIC
COSN30595677 130 COSMIC
COSN30493084 182 COSMIC
COSN30149122 187 COSMIC
COSN1946277 319 COSMIC
COSN15450188 718 COSMIC
COSN28631948 749 COSMIC
COSN8366156 846 COSMIC
COSN26562415 912 COSMIC
COSN31553393 1203 COSMIC
COSN31523457 1221 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1177894888 3 dbSNP
rs1436055523 5 dbSNP
rs754832857 8 dbSNP
rs751539558 13 dbSNP
rs143168802 16 dbSNP
rs1278390123 18 dbSNP
rs1219098150 20 dbSNP
rs1354814806 26 dbSNP
rs773211510 29 dbSNP
rs764401600 31 dbSNP
rs1217680219 32 dbSNP
rs1342844850 33 dbSNP
rs760986551 35 dbSNP
rs775640855 42 dbSNP
rs763380509 48 dbSNP
rs1310650702 51 dbSNP
rs972581556 54 dbSNP
rs775780310 56 dbSNP
rs547990260 58 dbSNP
rs1383146239 63 dbSNP
rs1300492509 68 dbSNP
rs949172874 71 dbSNP
rs1384649460 87 dbSNP
rs935539006 92 dbSNP
rs11058 100 dbSNP
rs1220057260 101 dbSNP
rs982283249 113 dbSNP
rs533322113 121 dbSNP
rs1305840341 122 dbSNP
rs568561464 125 dbSNP
rs1406241275 130 dbSNP
rs1034388459 132 dbSNP
rs1258697297 132 dbSNP
rs959547149 132 dbSNP
rs1254687820 136 dbSNP
rs978698295 142 dbSNP
rs1185584592 153 dbSNP
rs181674663 157 dbSNP
rs991610643 159 dbSNP
rs866200643 162 dbSNP
rs1461407667 165 dbSNP
rs773461320 167 dbSNP
rs1324410232 175 dbSNP
rs1397161151 176 dbSNP
rs529443889 181 dbSNP
rs191691275 198 dbSNP
rs1193763386 199 dbSNP
rs1216452905 205 dbSNP
rs1278887560 214 dbSNP
rs1334196981 218 dbSNP
rs768585415 220 dbSNP
rs564458427 221 dbSNP
rs1014819544 224 dbSNP
rs1008731158 226 dbSNP
rs890319827 227 dbSNP
rs1484357398 230 dbSNP
rs1263878682 236 dbSNP
rs1193885010 238 dbSNP
rs546340765 256 dbSNP
rs186851865 259 dbSNP
rs1020198729 263 dbSNP
rs1163410995 267 dbSNP
rs1420645643 270 dbSNP
rs1406375218 282 dbSNP
rs1158807988 284 dbSNP
rs1007177485 286 dbSNP
rs1298973698 289 dbSNP
rs996626179 290 dbSNP
rs890002654 291 dbSNP
rs1412937751 300 dbSNP
rs1203091800 301 dbSNP
rs1295118646 315 dbSNP
rs1321440955 331 dbSNP
rs181095231 336 dbSNP
rs1281929926 343 dbSNP
rs1318454251 350 dbSNP
rs995149361 372 dbSNP
rs542003892 379 dbSNP
rs1228706323 380 dbSNP
rs1279085193 389 dbSNP
rs1326219806 398 dbSNP
rs1293860296 407 dbSNP
rs746895392 408 dbSNP
rs896922555 408 dbSNP
rs574875446 425 dbSNP
rs1036809793 430 dbSNP
rs556628357 433 dbSNP
rs13078246 436 dbSNP
rs138727047 437 dbSNP
rs1467806454 445 dbSNP
rs924186365 448 dbSNP
rs1314799894 451 dbSNP
rs1341103087 455 dbSNP
rs1055356147 459 dbSNP
rs937951046 460 dbSNP
rs1168443652 475 dbSNP
rs758120803 480 dbSNP
rs1240599254 489 dbSNP
rs925162456 490 dbSNP
rs1461408785 491 dbSNP
rs1047119543 496 dbSNP
rs949667038 500 dbSNP
rs558594792 505 dbSNP
rs1166612404 509 dbSNP
rs1278748366 509 dbSNP
rs533948686 511 dbSNP
rs913218750 519 dbSNP
rs1231600238 530 dbSNP
rs1442001927 531 dbSNP
rs1179629065 532 dbSNP
rs1394752558 534 dbSNP
rs1452848034 543 dbSNP
rs1174489607 545 dbSNP
rs958417958 550 dbSNP
rs920375873 551 dbSNP
rs566554112 552 dbSNP
rs748060419 553 dbSNP
rs1402356978 560 dbSNP
rs1447305056 568 dbSNP
rs1339308415 574 dbSNP
rs1196939641 583 dbSNP
rs1236064322 585 dbSNP
rs1014837894 588 dbSNP
rs1275015355 594 dbSNP
rs1338186070 595 dbSNP
rs1009196561 596 dbSNP
rs554648498 600 dbSNP
rs536006127 603 dbSNP
rs145907759 605 dbSNP
rs1271573474 609 dbSNP
rs1459460362 610 dbSNP
rs954340229 612 dbSNP
rs1467374577 614 dbSNP
rs754861817 614 dbSNP
rs753522701 631 dbSNP
rs1378422240 635 dbSNP
rs1027212688 640 dbSNP
rs3805075 643 dbSNP
rs1425734733 649 dbSNP
rs996037836 668 dbSNP
rs893875743 675 dbSNP
rs1325078987 679 dbSNP
rs1449943836 682 dbSNP
rs149482251 685 dbSNP
rs999516384 689 dbSNP
rs1323880063 690 dbSNP
rs570766556 694 dbSNP
rs902481315 695 dbSNP
rs1325473381 696 dbSNP
rs1428091346 700 dbSNP
rs1271463407 707 dbSNP
rs1046395237 708 dbSNP
rs1219798540 711 dbSNP
rs1273036542 725 dbSNP
rs376128346 732 dbSNP
rs77579635 738 dbSNP
rs1268381767 739 dbSNP
rs1446604307 749 dbSNP
rs1317883395 753 dbSNP
rs1128199 754 dbSNP
rs1265451118 756 dbSNP
rs1478153465 758 dbSNP
rs1295169248 759 dbSNP
rs868218169 762 dbSNP
rs1054968276 764 dbSNP
rs1163597999 773 dbSNP
rs1055689593 779 dbSNP
rs931506074 781 dbSNP
rs1380192433 793 dbSNP
rs1425098957 803 dbSNP
rs920343222 809 dbSNP
rs1413629046 812 dbSNP
rs766956181 814 dbSNP
rs1293280809 818 dbSNP
rs1339207537 821 dbSNP
rs1247492172 833 dbSNP
rs1163192066 848 dbSNP
rs1442991290 855 dbSNP
rs200700819 860 dbSNP
rs925214244 860 dbSNP
rs1491091234 861 dbSNP
rs1488696507 864 dbSNP
rs866863414 867 dbSNP
rs1187293979 871 dbSNP
rs940454366 871 dbSNP
rs1255377472 878 dbSNP
rs1437807771 881 dbSNP
rs1425520778 883 dbSNP
rs763473927 891 dbSNP
rs753238754 895 dbSNP
rs1249077015 904 dbSNP
rs987175031 947 dbSNP
rs1363025139 952 dbSNP
rs1225285486 962 dbSNP
rs945294303 963 dbSNP
rs913269624 964 dbSNP
rs527881377 967 dbSNP
rs1310512140 968 dbSNP
rs1403667397 980 dbSNP
rs1028932398 981 dbSNP
rs1313986905 983 dbSNP
rs544281374 1000 dbSNP
rs1238425574 1005 dbSNP
rs1311810187 1011 dbSNP
rs1354655673 1014 dbSNP
rs965496334 1019 dbSNP
rs549969873 1024 dbSNP
rs1484244742 1031 dbSNP
rs1200969933 1036 dbSNP
rs564465617 1040 dbSNP
rs551001672 1041 dbSNP
rs1180256225 1046 dbSNP
rs1380574496 1050 dbSNP
rs1453450122 1053 dbSNP
rs1171304692 1059 dbSNP
rs999571739 1061 dbSNP
rs1360397739 1062 dbSNP
rs1466041225 1064 dbSNP
rs1304000459 1069 dbSNP
rs114485182 1071 dbSNP
rs1445090547 1072 dbSNP
rs530245840 1074 dbSNP
rs1333749515 1075 dbSNP
rs1325449349 1076 dbSNP
rs1405418959 1080 dbSNP
rs1364796097 1087 dbSNP
rs954387454 1088 dbSNP
rs1233864806 1094 dbSNP
rs1299382533 1096 dbSNP
rs1027135297 1098 dbSNP
rs762066527 1101 dbSNP
rs1387382896 1106 dbSNP
rs1013615074 1124 dbSNP
rs1456363672 1127 dbSNP
rs895370508 1138 dbSNP
rs995797107 1140 dbSNP
rs1238582423 1141 dbSNP
rs1159312255 1150 dbSNP
rs1469699121 1154 dbSNP
rs562992219 1155 dbSNP
rs1191360900 1158 dbSNP
rs1426820187 1160 dbSNP
rs879930615 1180 dbSNP
rs931474886 1180 dbSNP
rs1015273929 1182 dbSNP
rs1373048263 1184 dbSNP
rs530042078 1192 dbSNP
rs1173385336 1199 dbSNP
rs896255103 1203 dbSNP
rs1033816770 1205 dbSNP
rs1292062081 1206 dbSNP
rs1001946646 1214 dbSNP
rs1449051614 1220 dbSNP
rs1395771382 1221 dbSNP
rs1294989852 1232 dbSNP
rs898634807 1233 dbSNP
rs544583385 1236 dbSNP
rs1204114765 1237 dbSNP
rs1347938122 1239 dbSNP
rs1043534135 1247 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ucGUC-GUAAC---AUGUCCCGAUACu 5'
            :|| || ||   | || | ||: | 
Target 5' aaUAGCCACUGCACUCCA-GCCUGGG- 3'
13 - 37
Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ucGUCGUAACAU--GUCCCGauacu 5'
            | ||| |  |  | ||||     
Target 5' caCUGCACUCCAGCCUGGGC----- 3'
20 - 39
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HCT116
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in ERX177601. RNA binding protein: AGO2. Condition:KO_D_Ago_CLIP_2_3 PAR-CLIP data was present in ERX177602. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_4 PAR-CLIP data was present in ERX177625. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_3 ...

- Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research.

Article - Krell J; Stebbing J; Carissimi C; Dabrowska et al.
- Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
CLIP-seq Support 1 for dataset GSM545215
Method / RBP PAR-CLIP / AGO4
Cell line / Condition HEK293 / Control
Location of target site ENST00000396556.2 | 3UTR | AUUGCUCCUGUGAAUAGCCACUGCACUCCAGCCUGGG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000396556.2 | 3UTR | GAUUGCUCCUGUGAAUAGCCACUGCACUCCAGCCUGGGC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE28260 Renal cortex and medulla -0.469 5.3e-2 -0.582 1.8e-2 13 Click to see details
GSE28544 Breast cancer -0.038 4.3e-1 -0.173 2.1e-1 24 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
53 hsa-miR-103b Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT218386 E2F3 E2F transcription factor 3 2 2
MIRT404221 RPL7L1 ribosomal protein L7 like 1 2 2
MIRT441502 SPG20 spartin 2 6
MIRT444124 ZNRF3 zinc and ring finger 3 2 2
MIRT454236 OSBPL10 oxysterol binding protein like 10 2 4
MIRT457919 ZNF212 zinc finger protein 212 2 2
MIRT462254 LAMA4 laminin subunit alpha 4 2 2
MIRT463176 ZNF281 zinc finger protein 281 2 2
MIRT472355 TSPAN1 tetraspanin 1 2 2
MIRT474133 LIN54 lin-54 DREAM MuvB core complex component 2 4
MIRT494946 IFFO2 intermediate filament family orphan 2 2 2
MIRT497403 NPY4R neuropeptide Y receptor Y4 2 2
MIRT497641 GLDN gliomedin 2 2
MIRT505340 TMEM245 transmembrane protein 245 2 6
MIRT505680 SESTD1 SEC14 and spectrin domain containing 1 2 6
MIRT510706 SREK1IP1 SREK1 interacting protein 1 2 6
MIRT512198 C1orf43 chromosome 1 open reading frame 43 2 2
MIRT522089 NUFIP2 NUFIP2, FMR1 interacting protein 2 2 4
MIRT525074 FRK fyn related Src family tyrosine kinase 2 2
MIRT531276 PPIL3 peptidylprolyl isomerase like 3 2 2
MIRT535119 PLXNA2 plexin A2 2 2
MIRT540836 GNAT1 G protein subunit alpha transducin 1 2 4
MIRT541018 WIPI2 WD repeat domain, phosphoinositide interacting 2 2 2
MIRT545752 CA12 carbonic anhydrase 12 2 4
MIRT546404 SRP9 signal recognition particle 9 2 2
MIRT547991 HCFC2 host cell factor C2 2 4
MIRT554502 SAE1 SUMO1 activating enzyme subunit 1 2 2
MIRT558360 DMTF1 cyclin D binding myb like transcription factor 1 2 2
MIRT558863 CD2AP CD2 associated protein 2 2
MIRT559939 ZNF567 zinc finger protein 567 2 2
MIRT566300 PPM1A protein phosphatase, Mg2+/Mn2+ dependent 1A 2 2
MIRT567490 FOXK1 forkhead box K1 2 2
MIRT617139 ZNF556 zinc finger protein 556 2 2
MIRT625400 AKR7L aldo-keto reductase family 7 like (gene/pseudogene) 2 2
MIRT626491 CEP89 centrosomal protein 89 2 2
MIRT629487 GSN gelsolin 2 4
MIRT638456 PLXDC2 plexin domain containing 2 2 2
MIRT648498 CMBL carboxymethylenebutenolidase homolog 2 2
MIRT654845 PPM1L protein phosphatase, Mg2+/Mn2+ dependent 1L 2 2
MIRT664587 HSD17B12 hydroxysteroid 17-beta dehydrogenase 12 2 2
MIRT664977 TDRD1 tudor domain containing 1 2 2
MIRT665028 ELK1 ELK1, ETS transcription factor 2 2
MIRT666043 STON2 stonin 2 2 2
MIRT668863 CRY2 cryptochrome circadian clock 2 2 2
MIRT669297 C17orf85 nuclear cap binding subunit 3 2 2
MIRT680975 DCAF17 DDB1 and CUL4 associated factor 17 2 2
MIRT682267 RS1 retinoschisin 1 2 2
MIRT685283 KIAA1143 KIAA1143 2 2
MIRT693375 PIGP phosphatidylinositol glycan anchor biosynthesis class P 2 2
MIRT701785 MSL1 male specific lethal 1 homolog 2 2
MIRT709373 SPECC1 sperm antigen with calponin homology and coiled-coil domains 1 2 2
MIRT715154 IL12B interleukin 12B 2 2
MIRT734499 ADAMTS5 ADAM metallopeptidase with thrombospondin type 1 motif 5 3 0
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-1 Anthocyanin NULL 145858 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Caffeic acid NULL 689043 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Catechin approved 9064 Microarray apoE−/− mice 22253797 2012 up-regulated
miR-1 Curcumin NULL 969516 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Ferulic acid NULL 445858 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Hesperidin NULL 10621 Microarray apoE−/− mice 22253797 2012 up-regulated
miR-1 Quercetin NULL 5280343 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Galactose NULL 6036 Quantitative real-time PCR lens 22736950 2012 up-regulated
miR-1 Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse brain 19270793 2009 down-regulated
miR-1 Trichostatin A (TSA) NULL 444732 Quantitative real-time PCR myocardial differentiation of mouse ES cells 19521018 2009 down-regulated
miR-1 Sulfonyl-hydrazone-1 (SHZ) NULL NULL Quantitative real-time PCR Murine broblast-derived Induced pluripotent stem cells 21445862 2011 up-regulated
miR-1 Cocaine NULL 446220 Next-generation sequencing ventral striatum 21708909 2011 up-regulated
miR-1 Atorvastatin approved 60823 Quantitative real-time PCR Cardiomyocyte 23860036 2013 down-regualted
miR-1 Glucose NULL 5793 Quantitative real-time PCR endothelial cells 24394957 2014 down-regulated
miR-1 Docosahexaenoic acid NULL 445580 Quantitative real-time PCR Caco-2 cells 24623846 2014 up-regulated
miR-1 Palmitic acid approved 985 Quantitative real-time PCR Caco-2 cells 24623846 2014 up-regulated
miR-1 17beta-estradiol (E2) approved 5757 Microarray MCF-7AKT breast cancer cells 19528081 2009 down-regulated
miR-1 Essential amino acids (EAA) NULL NULL Quantitative real-time PCR skeletal muscle of young adults 19828686 2009 up-regulated
miR-1 Hydrogen peroxide (H2O2) NULL 784 Quantitative real-time PCR Human umbilical vein endothelial cells 21527937 2011 down-regulated
miR-1 Trichostatin A (TSA) NULL 444732 Microarray apoptosis-resistant breast cancer cells 21971930 2011 up-regulated
miR-1 Arsenic trioxide approved 14888 Quantitative real-time PCR acute promyelocytic leukemia 22072212 2012 up-regulated
miR-1 5-Fluorouracil approved 3385 Microarray CNE cells 22614822 2012 up-regulated
miR-1 Bicalutamide approved 2375 Microarray prostate 22674191 2012 up-regulated
miR-1 Arsenic trioxide approved 14888 Quantitative real-time PCR cardia 22889704 2012 up-regulated
miR-1 Perfluorooctane sulfonate NULL 74483 Microarray zebrafish embryos 20878907 2011 up-regulated
miR-1 Quinidine approved 441074 Quantitative real-time PCR myocardial infarction (MI) rats 19775284 2009 up-regulated
miR-1 Tanshinone IIA NULL 164676 Quantitative real-time PCR myocardial infarction (MI) rats 19775284 2009 down-regulated
miR-1 Tanshinone IIA NULL 164676 Quantitative real-time PCR post-infarction rat cardiomyocytes 21220930 2011 down-regulated
miR-1 Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 down-regulated
miR-1 Dexamethasone approved 5743 Microarray adrenals and granulosa cells 24205079 2014 up-regulated
miR-1 Thiourea (TU) NULL 737139 Quantitative real-time PCR skeletal muscle and heart 22142802 2012 up-regulated
miR-1 Thiourea (TU) NULL 737139 Quantitative real-time PCR skeletal muscle and heart 22142802 2012 down-regulated
miR-1 Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-103b Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-miR-103b Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-103b Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-103b Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-103b Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-miR-103b Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-103b Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)

Error report submission